Health
Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate – The Guardian
Researchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
CoronavirusResearchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
Although extremely rare, a blood clot syndrome after the first dose of the Oxford/AstraZeneca vaccine carries a high risk of death…
Continue Reading
-
General11 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business11 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General13 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General14 hours agoAlbanese beats drum on economy as trade clouds gather